182 related articles for article (PubMed ID: 22662180)
1. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
Stautz D; Wewer UM; Kveiborg M
PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
Dyczynska E; Syta E; Sun D; Zolkiewska A
Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
[TBL] [Abstract][Full Text] [Related]
4. Cell-surface metalloprotease ADAM12 is internalized by a clathrin- and Grb2-dependent mechanism.
Stautz D; Leyme A; Grandal MV; Albrechtsen R; van Deurs B; Wewer U; Kveiborg M
Traffic; 2012 Nov; 13(11):1532-46. PubMed ID: 22882974
[TBL] [Abstract][Full Text] [Related]
5. Cellular roles of ADAM12 in health and disease.
Kveiborg M; Albrechtsen R; Couchman JR; Wewer UM
Int J Biochem Cell Biol; 2008; 40(9):1685-702. PubMed ID: 18342566
[TBL] [Abstract][Full Text] [Related]
6. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 induces estrogen-independence in breast cancer cells.
Roy R; Moses MA
Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
[TBL] [Abstract][Full Text] [Related]
8. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
9. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.
Bourd-Boittin K; Le Pabic H; Bonnier D; L'Helgoualc'h A; Théret N
J Biol Chem; 2008 Sep; 283(38):26000-9. PubMed ID: 18621736
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme.
Wewer UM; Mörgelin M; Holck P; Jacobsen J; Lydolph MC; Johnsen AH; Kveiborg M; Albrechtsen R
J Biol Chem; 2006 Apr; 281(14):9418-22. PubMed ID: 16455653
[TBL] [Abstract][Full Text] [Related]
11. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.
Albrechtsen R; Stautz D; Sanjay A; Kveiborg M; Wewer UM
Exp Cell Res; 2011 Jan; 317(2):195-209. PubMed ID: 20951132
[TBL] [Abstract][Full Text] [Related]
12. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity.
Stautz D; Sanjay A; Hansen MT; Albrechtsen R; Wewer UM; Kveiborg M
Exp Cell Res; 2010 Jan; 316(1):55-67. PubMed ID: 19769962
[TBL] [Abstract][Full Text] [Related]
13. ADAM12: a potential target for the treatment of chronic wounds.
Harsha A; Stojadinovic O; Brem H; Sehara-Fujisawa A; Wewer U; Loomis CA; Blobel CP; Tomic-Canic M
J Mol Med (Berl); 2008 Aug; 86(8):961-9. PubMed ID: 18604515
[TBL] [Abstract][Full Text] [Related]
14. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
[TBL] [Abstract][Full Text] [Related]
15. Intracellular processing of metalloprotease disintegrin ADAM12.
Cao Y; Kang Q; Zhao Z; Zolkiewska A
J Biol Chem; 2002 Jul; 277(29):26403-11. PubMed ID: 12000744
[TBL] [Abstract][Full Text] [Related]
16. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of ADAM12 gene in breast cancers.
Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
[TBL] [Abstract][Full Text] [Related]
19. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation.
Kveiborg M; Albrechtsen R; Rudkjaer L; Wen G; Damgaard-Pedersen K; Wewer UM
J Bone Miner Res; 2006 Aug; 21(8):1288-96. PubMed ID: 16869727
[TBL] [Abstract][Full Text] [Related]
20. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
